Silenseed's Unattributed Round

Silenseed raised a round of funding on April 08, 2014.

Silenseed develops a novel platform for cancer therapies. The company is completing Phase I/II clinical study in patients with pancreatic cancer, and is moving toward a multinational Phase II/III stud…

Articles about Silenseed's Unattributed Round: